The Real‐World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Patients with Type 2 Diabetes (TROPHIES): Patient disposition, clinical characteristics and treatment persistence at 12 months

AIMS: The primary objective of the TROPHIES observational study is to estimate the duration of treatment on dulaglutide or liraglutide without a significant treatment change by 24 months in patients with type 2 diabetes (T2D) initiating their first injectable treatment with these glucagon‐like pepti...

Descripción completa

Detalles Bibliográficos
Autores principales: Guerci, Bruno, Giorgino, Francesco, Sapin, Hélène, Boye, Kristina, Lebrec, Jérémie, Federici, Marco Orsini, Heitmann, Elke, Dib, Anne, Füchtenbusch, Martin, García‐Pérez, Luis‐Emilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804517/
https://www.ncbi.nlm.nih.gov/pubmed/35876235
http://dx.doi.org/10.1111/dom.14823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804517/
https://www.ncbi.nlm.nih.gov/pubmed/35876235
http://dx.doi.org/10.1111/dom.14823

Ejemplares similares